RightFit
RecruitingPhase not listed

The Hepatitis C Transplant Collaborative

Nationwide Hepatitis C NAT+ Cardiac Transplant Experience

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at safety and health results after a heart transplant using a donor heart that tests positive for hepatitis C virus. It is for people who received one of these hearts, including people who have had a heart transplant before.

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Received a donor heart with a confirmed positive HCV NAT test, which detects hepatitis C virus.
  • People receiving another heart transplant may join.

Who can't join

  • Received more than one type of organ in the transplant.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Recipient of a proven HCV NAT+ donor heart. 2. Re-transplant patients will be included. Exclusion Criteria: 1\. Multi-organ transplantation

Study sites (1)

TX